Board Meeting30 Jul 2026, 07:20 pm
Shukra Pharmaceuticals Board Meeting on Aug 11, 2026
AI Summary
Shukra Pharmaceuticals Ltd has announced that its Board of Directors will convene on August 11, 2026. The primary agenda items include the consideration and approval of the unaudited financial results for the quarter ended June 30, 2026, along with the accompanying Auditor's Limited Review Report. The meeting will also address any other business as permitted by the Chairman. This announcement is made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Highlights
- Board meeting scheduled for August 11, 2026.
- To approve unaudited financial results for Q1 FY27.
- Auditor's Limited Review Report to be considered.
- Meeting to be held at the company's registered office.
Price Impact
More from SHUKRAPHAR